Estimation of Homocysteine Level in Sudanese Obese, Gezira State, Sudan
DOI:
https://doi.org/10.14738/jbemi.94.12718Keywords:
Homocysteine, body mass index, obesity, SudanAbstract
Science-based evidence on the association of total homocysteine (Hcy) with body mass index (BMI), as well as obesity and elevated Hcy levels, in the general population has been conflicted .The primary goals of this case control study is to evaluate the relationship between Hcy concentration and obesity in Gezira state in Sudan. A total of 221 participants including 140 obese , their average age was 49.49±12.2 years, divided into three groups on the basis of BMI according to the WHO classification and the groups constituted 44 obese type I , 51 obese type II and 45 obese type III , the control group was normal weight (BMI < 25.9) include 81 participants ,their age medium were 45.78±22.38 years .Three mL of venous blood from each participant was collected in the morning after a twelve hours overnight fasting in lithium heparin container, then the separated plasma was stored at −80 ◦C for further analysis. Serum Hcy was measured using the enzymatic method by Cobas C 411analyzer. The cut-off value for normal levels of Hcy is 15 μmol/L , out of 140 obese, there were 43(30.7%) having hyperhomocysteinemia (HHcy).The Hcy average increased in obese (12.65±4.9) in comparing with control(10.45±3.8) giving significant difference (P value 0.002). The mean values of Hcy were also compared among the various obesity types. It was found that there was no statistically significant (P value0.628). Pearson correlation analyses showed that BMI was negatively associated with Hcy (r-0.027, P value 0.754). The mean of Hcy was decreased in the lower age group (20 – 40 years), and increased in the higher age group (61 – 80years) showing no significant difference but age is positively correlated with high level of Hcy (r 0.094, P value: 0.268). The study finding showed significant relationship between Hcy and obesity. However, the Hcy concentrations were not positively correlated with the degree of obesity, further studies are needed to ascertain the causal role of Hcy in the development of obesity and to explore how Hcy is involved in the pathogenesis of obesity.
References
Rull A, Camps J, Alonso-Villaverde C, Joven JJMoi. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism. 2010;2010.
Škovierová H, Vidomanová E, Mahmood S, Sopková J, Drgová A, Červeňová T, et al. The molecular and cellular effect of homocysteine metabolism imbalance on human health. 2016;17(10):1733.
Tehlivets O. Homocysteine as a risk factor for atherosclerosis: is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism? Journal of lipids. 2011;2011.
Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SNJN, et al. The metabolism and significance of homocysteine in nutrition and health. 2017;14(1):1-12.
Pitt SB, Giugliani R, Felix TM. Genetics of homocysteine metabolism and associated disorders. Brazilian journal of medical and biological research= Revista brasileira de pesquisas médicas e biológicas Ribeirao Preto Vol 43, n 1 (jan 2010), p 1-7. 2010.
Brustolin S, Giugliani R, Félix T. Genetics of homocysteine metabolism and associated disorders. Brazilian Journal of Medical and Biological Research. 2010;43(1):1-7.
Xiang Y, Zhao Q, Wang N, Yu Y, Wang R, Zhang Y, et al. Association of Obesity with the Risk of Hyperhomocysteinemia among the Chinese Community Residents: A Prospective Cohort Study in Shanghai, China. 2021;13(10):3648.
Wang Y, Jiang Y, Wang N, Zhu M, Liu X, Wang R, et al. Central but not general obesity is positively associated with the risk of hyperhomocysteinemia in middle-aged women. 2019;11(7):1614.
BeÅ J, Tokarzewska DJBR. Adipose tussue and homocysteine metabolism. 2009;20:7-15.
Saldaña-Alvarez Y, Salas-Martínez MG, García-Ortiz H, Luckie-Duque A, García-Cárdenas G, Vicenteño-Ayala H, et al. Gender-dependent association of FTO polymorphisms with body mass index in Mexicans. PLoS One. 2016;11(1):e0145984.
James PTJCid. Obesity: the worldwide epidemic. 2004;22(4):276-80.
Wang J, You D, Wang H, Yang Y, Zhang D, Lv J, et al. Association between homocysteine and obesity: a metaanalysis. 2021;14(3):208-17.
Motaung S, Sengwayo D, Moraba MJSAJoD, Disease V. Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity. 2017;14(1):33-7.
Park SB, Georgiades AJJoKms. Changes in body composition predict homocysteine changes and hyperhomocysteinemia in Korea. 2013;28(7):1015-20.
Fan H, Li X, Zheng L, Chen X, Wu H, Ding X, et al. Abdominal obesity is strongly associated with Cardiovascular Disease and its Risk Factors in Elderly and very Elderly Community-dwelling Chinese. 2016;6(1):1-9.
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. 2008;359(20):2105-20.
Sponholtz TR, van den Heuvel ER, Xanthakis V, Vasan RSJJotAHA. Association of variability in body mass index and metabolic health with cardiometabolic disease risk. 2019;8(7):e010793.
Xu R, Huang F, Wang Y, Liu Q, Lv Y, Zhang QJSR. Gender-and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. 2020;10(1):1-11.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Hala Abdelazeem, Adil Mergani, Yousif Abdelhameed Mohammed, Khalid Abdelsamea M. Ahmaed, Bakri Yousif Mohamed Nour

This work is licensed under a Creative Commons Attribution 4.0 International License.